Drug Profile
Research programme: botanical drugs - General Research Laboratory
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator General Research Laboratory
- Class
- Mechanism of Action Apoptosis stimulants; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Fracture; Infections; Wounds
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Cancer in USA
- 28 Sep 2020 No recent reports of development identified for research development in Fracture in USA
- 28 Sep 2020 No recent reports of development identified for research development in Infections in USA